Compositions and methods for producing tobacco plants and products having altered alkaloid levels

Patent metadata

Field	Value
Publication number	US-11950563-B2
Application number	US-201916246308-A
Country	US
Kind code	B2
Filing date	Jan 11, 2019
Priority date	Jan 12, 2018
Publication date	Apr 9, 2024
Grant date	Apr 9, 2024

Abstract

The present disclosure provides tobacco Nic1b locus and associated genes (e.g., a group of ERF genes). Also provided are tobacco plants with altered total alkaloid and nicotine levels and commercially acceptable leaf grade, their development via breeding or transgenic approaches, and production of tobacco products from these tobacco plants. Further provided are compositions and methods for producing tobacco plants having novel mutations or alleles to reduce nicotine levels. Further provided are sequence polymorphisms and molecular markers for breeding tobacco with reduced nicotine or alkaloids while maintaining tobacco leaf grade and tobacco product quality.

First claim

The invention claimed is:

1. A tobacco plant, or part thereof, comprising a non-natural mutation in an ethylene responsive factor (ERF) gene, wherein said non-natural mutation down-regulates the expression or function of said ERF gene, wherein said non-natural mutation is located within an ERF gene that comprises an endogenous sequence having 100% identity to a sequence selected from the group consisting of SEQ ID NOs: 3, 13, 14, 17, 18, 19, 38, 48, 49, 52, 53, 54, and 202 to 204, and wherein said tobacco plant is capable of producing a leaf, when cured, having a USDA grade index value of 50 or more.

2. The tobacco plant, or part thereof, of claim 1 , wherein said tobacco plant is a Nicotiana tabacum plant.

3. The tobacco plant, or part thereof, of claim 2 , wherein said tobacco plant further comprises a mutation in an ethylene responsive factor (ERF) gene of a Nic2 locus.

4. The tobacco plant, or part thereof, of claim 2 , wherein said tobacco plant further comprises one or more mutations in two or more, three or more, four or more, five or more, six or more, or all seven ethylene responsive factor (ERF) genes selected from the group consisting of ERF 189, ERF 115, ERF221, ERF 104, ERF 179, ERF 17, and ERF 168.

5. The tobacco plant, or part thereof, of claim 2 , wherein said tobacco plant is capable of producing a leaf, when cured, having a USDA grade index value of 70 or more.

6. The tobacco plant, or part thereof, of claim 2 , wherein said tobacco plant is capable of producing a leaf, when cured, having a USDA grade index value comparable to that of a control plant when grown and cured in similar conditions, wherein said control plant shares an essentially identical genetic background with said tobacco plant except said mutation.

7. The tobacco plant, or part thereof, of claim 2 , wherein said tobacco plant comprises nicotine at a level below 40% of the nicotine level of a control plant when grown in similar growth conditions, wherein said control plant shares an essentially identical genetic background with said tobacco plant except said mutation.

8. The tobacco plant, or part thereof, of claim 2 , wherein said tobacco plant comprises a nicotine level less than 2.0%.

9. A tobacco plant, or part thereof, comprising a non-transgenic and non-natural mutation in an ethylene responsive factor (ERF) gene, wherein said non-transgenic and non-natural mutation down-regulates the expression or function of said ERF gene, wherein said non-transgenic and non-natural mutation is located within an ERF gene that comprises an endogenous sequence having 100% identity to a sequence selected from the group consisting of SEQ ID NOs: 3, 13, 14, 17, 18, 19, 38, 48, 49, 52, 53, 54, and 202 to 204, and wherein said non-transgenic and non-natural mutation reduces the nicotine level of said tobacco plant to below 60% of the nicotine level of a control plant when grown in similar growth conditions, wherein said tobacco plant is capable of producing a leaf, when cured, having a USDA grade index value comparable to the USDA grade index value of said control plant, wherein said control plant shares an essentially identical genetic background with said tobacco plant except said non-transgenic and non-natural mutation, and wherein said tobacco plant is a Nicotiana tabacum plant.

10. A population of the tobacco plants of claim 2 .

11. Cured tobacco material from the tobacco plant of claim 2 .

12. The cured tobacco material of claim 11 , wherein said cured tobacco material is made by a curing process selected from the group consisting of flue curing, air curing, fire curing, and sun curing.

13. A tobacco blend comprising said cured tobacco material of claim 11 .

14. A tobacco product comprising said cured tobacco material of claim 11 .

15. The tobacco product of claim 14 , wherein said tobacco product is selected from the group consisting of a cigarette, a cigarillo, a non-ventilated recess filter cigarette, a vented recess filter cigarette, a cigar, snuff, pipe tobacco, cigar tobacco, cigarette tobacco, chewing tobacco, leaf tobacco, shredded tobacco, and cut tobacco.

16. The tobacco product of claim 14 , wherein said tobacco product is a smokeless tobacco product.

17. The tobacco product of claim 16 , wherein said smokeless tobacco product is selected from the group consisting of loose leaf chewing tobacco, plug chewing tobacco, moist snuff, and nasal snuff.

18. A tobacco plant, or part thereof, comprising a non-natural mutation in an ethylene responsive factor (ERF) gene, wherein said non-natural mutation is located within an ERF gene that comprises an endogenous sequence having 100% identity to a sequence selected from the group consisting of SEQ ID NOs:
3, 13, 14, 17, 18, 19, 38, 48, 49, 52, 53, 54, and 202 to 204, wherein said non-natural mutation down-regulates the expression or function of said ERF gene, wherein said non-natural mutation is absent from the tobacco lines LA Burley 21, LAFC53, and LN KY171; and wherein said tobacco plant is from a variety selected from the group consisting of flue-cured tobacco, dark fire-cured tobacco, Galpão tobacco, and Oriental tobacco.

19. The tobacco plant, or part thereof, of claim 18 , wherein said tobacco plant further comprises a mutation in an ethylene responsive factor (ERF) gene of a Nic2 locus.

20. The tobacco plant, or part thereof, of claim 18 , wherein said tobacco plant is from a variety selected from the group consisting of Burley tobacco, Maryland tobacco, and dark air-cured tobacco.

21. Cured tobacco material from said tobacco plant of claim 18 .

22. The cured tobacco material of claim 21 , wherein said cured tobacco material is from a tobacco plant selected from the group consisting of flue-cured tobacco, fire-cured tobacco, and sun-cured tobacco.

23. A tobacco product comprising the cured tobacco material of claim 21 .

24. The tobacco product of claim 21 , wherein said tobacco product is selected from the group consisting of a cigarette, a cigarillo, a non-ventilated recess filter cigarette, a vented recess filter cigarette, a cigar, snuff, pipe tobacco, cigar tobacco, cigarette tobacco, chewing tobacco, leaf tobacco, shredded tobacco, and cut tobacco.

25. The tobacco product of claim 23 , wherein said tobacco product is a smokeless tobacco product.

Assignees

• Altria Client Services Llc

Inventors

• Pramod Sreepriya
• De Godoy Lusso Marcos Fernando
• Frederick Jesse
• Adams Andrew Carl
• Xu Dongmei

Classifications

• A01H6/823 Primary

  Nicotiana, e.g. tobacco · CPC title

• A01H1/06

  Processes for producing mutations, e.g. treatment with chemicals or with radiation (specific mutations prepared by genetic engineering on plant cell or plant tissues C12N15/00 {; process for producing transgenic plants C12N15/82}) · CPC title

• A24B3/08

  Blending tobacco · CPC title

• A24B3/12

  Steaming, curing, or flavouring tobacco · CPC title

• A24B13/00

  Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff (reconstituted tobacco products A24B3/14) · CPC title